Skip to main content
The Website Services team at NHS England are testing early designs to understand how you find information. Your views will help us check our ideas work. Sign up to take part in our user research.

Cancer 62 Day Patient Tracking List (CANPTL) data collection Annex A

Section 1 62 day Patient Tracking List (PTL) patients without a decision to treat

section1 day PTL patients without a decision to treat

 

1.1 urgent suspected cancer

Tumour type of the pathway which the patient is on 

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

Patients waiting from referral or upgrade by days waited on midnight Sunday of the reporting week by 

  • day  - 0 - 28
  • day 20 - 62
  • day 63 - 104
  • more than day 104

Number of patients by referral type passing 28, 62 and 104 days from referral upgrade in the last 7 days to midnight Sunday of the reporting week by

  • number passing day 29 in last 7 days
  • number passing day 62 in last 7 days
  • number passing day 104 in last 7 days

 

1.2 Urgent breast symptomatic 

Exhibited (non cancer) breast symptoms  - cancer not initially suspected

Patients waiting from referral or upgrade by days waited on midnight Sunday of the reporting week  

  • day  - 0 - 28
  • day 20 - 62
  • day 63 - 104
  • more than day 104

Number of patients by referral type passing 28, 62 and 104 days from referral upgrade in the last 7 days to midnight Sunday of the reporting week

  • number passing day 29 in last 7 days
  • number passing day 62 in last 7 days
  • number passing day 104 in last 7 days
1.3 Urgent screening

Tumour type of the pathway which the patient is on

  • breast
  • gynaecological
  • lower gastrointestinal 

Patients waiting from referral or upgrade by days waited on midnight Sunday of the reporting week by 

  • day  - 0 - 28
  • day 20 - 62
  • day 63 - 104
  • more than day 104

Number of patients by referral type passing 28, 62 and 104 days from referral upgrade in the last 7 days to midnight Sunday of the reporting week by

  • number passing day 29 in last 7 days
  • number passing day 62 in last 7 days
  • number passing day 104 in last 7 days
1.4 Consultant upgrade by tumour type of the pathway which the patient is on by 

Consultant upgrade  by tumour type of the pathway which the patient is on 

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

Patients waiting from referral or upgrade by days waited on midnight Sunday of the reporting week 

  • day  - 0 - 28
  • day 20 - 62
  • day 63 - 104
  • more than day 104

Number of patients by referral type passing 28, 62 and 104 days from referral upgrade in the last 7 days to midnight Sunday of the reporting week

  • number passing day 29 in last 7 days
  • number passing day 62 in last 7 days
  • number passing day 104 in last 7 days

Section 2

section 2 62 day PRL patients with decision to treat

2.1 Urgent suspected cancer

Tumour type of the pathway which the patient is on

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

Patients waiting from referral or upgrade by days waited on midnight Sunday of the reporting week 

  • day 0 - 28
  • day 20 - 62
  • day 63 - 104
  • more than day 104

Number of patients passing 28, 62 and 104 days from referral/upgrade in the last 7 days (to midnight Sunday of the reporting week)

  • number passing day 28 in last 7 days
  • number passing day 62 in last 7 days
  • number passing day 104 in last 7 days

Section 3

section 3 patients treated in the last week to midnight Sunday of the reporting week who were referred urgently for a suspected cancer

Patients treated in the last week (to midnight Sunday of the reporting week) who were referred urgently for a suspected cancer
  • number of patients treated by day 62
  • number of patients treated day 63  - 104
  • number of patients treated day greater than 104 

Section 4 Referrals and upgrades made

referrals upgrades made

Number of referrals or upgrades made in the last 7 days

Referral type

1.1 Urgent suspected cancer

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

Number of referrals/upgrades made in the last 7 days (to midnight Sunday of the reporting week) 

1.2 Urgent breast symptomatic

exhibited (non cancer) breast symptoms - cancer not initially suspected

1.3 Urgent screening

Urgent breast screening - breast 

urgent cervical screening - gynaecological 

urgent bowel screening - lower gastrointestinal

1.4 consultant upgrade

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

 


Section 5 urgent suspected cancer

urgent suspected cancer referrals seen table

Urgent suspected cancer referrals seen

Urgent suspected cancer first seen on 2 week wait urgent suspected cancer referral (face to face or video telephone) in the last 7 days (to midnight Sunday of the reporting week).

First seen on 2 week wait urgent suspected cancer referral (face to face or video telephone) in the last 7 days (to midnight Sunday of the reporting week) by number of the following suspected cancer types. 

  • brain/central nervous system
  • breast
  • children's 
  • gynaecological
  • haematological
  • head and neck 
  • lower gastrointestinal 
  • lung
  • sarcoma
  • skin
  • upper gastrointestinal 
  • urological
  • other 
  • none site specific symptoms

 

Last edited: 24 May 2022 9:22 am